NCT00005042View on ClinicalTrials.gov

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions
Sarcoma
Interventions
DRUG

semaxanib

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

90024

UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

AIDS Malignancy Consortium

NETWORK

NCT00005042 - SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter